C. Difficile:

​

Ferring Pharmaceuticals SCOPE study

A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults with Recurrent Clostridioides difficile Infection

​Study Details | A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection | ClinicalTrials.gov